SBF
ABBV icon

Sara-Bay Financial’s AbbVie ABBV Stock Holding History

Sara-Bay Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.56M Sell
18,132
-10
-0.1% -$2.15K 1.22% 14
2026
Q1 		$3.95M Buy
18,142
+525
+3% +$116K 1.19% 14
2025
Q4 		$4.05M Buy
17,617
+438
+3% +$99.8K 1.21% 12
2025
Q3 		$3.98M Buy
17,179
+3,002
+21% +$611K 1.11% 12
2025
Q2 		$2.63M Sell
14,177
-429
-3% -$79.7K 0.94% 12
2025
Q1 		$3M Buy
14,606
+977
+7% +$190K 1.32% 12
2024
Q4 		$2.4M Buy
13,629
+247
+2% +$45.4K 0.89% 14
2024
Q3 		$2.64M Sell
13,382
-408
-3% -$76.1K 0.96% 17
2024
Q2 		$2.37M Buy
13,790
+466
+3% +$77.2K 0.96% 16
2024
Q1 		$2.41M Buy
13,324
+857
+7% +$148K 1.08% 16
2023
Q4 		$1.93M Buy
12,467
+7
+0.1% +$1.02K 0.94% 17
2023
Q3 		$1.86M Sell
12,460
-126
-1% -$18.5K 0.94% 16
2023
Q2 		$1.7M Buy
12,586
+85
+0.7% +$12.5K 0.82% 17
2023
Q1 		$1.99M Sell
12,501
-861
-6% -$132K 1.01% 16
2022
Q4 		$2.16M Sell
13,362
-53
-0.4% -$8.13K 1.21% 15
2022
Q3 		$1.8M Sell
13,415
-82
-0.6% -$11.8K 1% 18
2022
Q2 		$2.08M Sell
13,497
-26
-0.2% -$3.97K 1.01% 19
2022
Q1 		$2.19M Buy
13,523
+489
+4% +$71K 0.87% 17
2021
Q4 		$1.76M Buy
13,034
+2,624
+25% +$310K 0.53% 20
2021
Q3 		$1.12M Buy
10,410
+46
+0.4% +$5.26K 0.44% 21
2021
Q2 		$1.17M Buy
10,364
+1,155
+13% +$130K 0.44% 22
2021
Q1 		$997K Buy
9,209
+2,411
+35% +$258K 0.41% 23
2020
Q4 		$728K Buy
6,798
+1,796
+36% +$173K 0.33% 26
2020
Q3 		$438K Buy
5,002
+105
+2% +$9.88K 0.24% 44
2020
Q2 		$484K Buy
+4,897
New +$431K 0.28% 38

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sara-Bay Financial's ABBV Position: Q2 2026 in Review

Sara-Bay Financial reduced its AbbVie (ABBV) stake by 0.06% in Q2 2026, selling an estimated $2.15K and leaving 18,132 shares worth $4.56M. The position accounts for 1.22% of the portfolio, ranked #14.

Sara-Bay Financial first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sara-Bay Financial held 18,132 shares of AbbVie worth $4.56M as of Q2 2026.
  • Sara-Bay Financial sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 1.22% of Sara-Bay Financial's portfolio in Q2 2026, its #14 holding.
  • Sara-Bay Financial first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sara-Bay Financial's 13F filing for Q2 2026, filed 17 Jul 2026.